Jump Financial’s AnaptysBio ANAB Stock Holding History

Jump Financial’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$216K	Sell	3,900 -116,317	-97%	-$6.26M	﹤0.01%	1630
2025 Q4	$5.83M	Buy	120,217 +38,140	+46%	+$1.49M	0.07%	338
2025 Q3	$2.51M	Buy	+82,077	New	+$1.88M	0.03%	656
2024 Q4	–	Sell	-39,032	Closed	-$1.31M	–	1616
2024 Q3	$1.31M	Buy	39,032 +3,332	+9%	+$114K	0.03%	681
2024 Q2	$895K	Buy	+35,700	New	+$831K	0.02%	867
2023 Q3	–	Sell	-29,260	Closed	-$595K	–	1817
2023 Q2	$595K	Buy	+29,260	New	+$593K	0.02%	945
2023 Q1	–	Sell	-18,730	Closed	-$580K	–	1554
2022 Q4	$580K	Buy	18,730 +5,281	+39%	+$149K	0.03%	715
2022 Q3	$343K	Sell	13,449 -1,976	-13%	-$46.3K	0.01%	1074
2022 Q2	$313K	Buy	+15,425	New	+$342K	0.01%	1040
2021 Q4	–	Sell	-11,900	Closed	-$323K	–	1354
2021 Q3	$323K	Buy	+11,900	New	+$302K	0.02%	630

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jump Financial's ANAB Position: Q1 2026 in Review

Jump Financial reduced its AnaptysBio (ANAB) stake by 97% in Q1 2026, selling an estimated $6.26M and leaving 3,900 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #1630.

Jump Financial first reported a position in ANAB in Q3 2021 and has held it in 10 quarters since. The position peaked at $5.83M in Q4 2025. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Jump Financial held 3,900 shares of AnaptysBio worth $216K as of Q1 2026.
Jump Financial sold 116,317 AnaptysBio shares in Q1 2026, an estimated $6.26M.
AnaptysBio made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1630 holding.
Jump Financial first reported a position in AnaptysBio in Q3 2021 and has held it in 10 quarters since.
Jump Financial's AnaptysBio position peaked at $5.83M in Q4 2025.
207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.